Skip to content

Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities

Frederic Sampedro, Mario de la Fuente Revenga, Marta Valle, Natalia Roberto, Elisabet Domínguez‐clavé, Matilde Elices, Luís Eduardo Luna, José Alexandre S. Crippa, Jaime E. C. Hallak, Dráulio Barros de Araújo, Pablo Friedländer, Steven A. Barker, Enric Álvarez, Joaquim Soler, Juan Carlos Pascual, Amanda Feilding, Jordi Riba

The International Journal of Neuropsychopharmacology May 17, 2017 DOI: 10.1093/ijnp/pyx036 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Open-label uncontrolled study Peer reviewed
Sample size 16
Population Healthy volunteers
Intervention Ayahuasca
Dose a single ayahuasca dose
Topics Ayahuasca Meditation
Keywords Functional connectivity Hallucinogen Psychotherapist Clinical psychology
Citations 205
Key points Post-acute reductions in glutamate+glutamine in the posterior cingulate cortex correlated with increased nonjudging, and increased anterior cingulate cortex-medial temporal lobe connectivity correlated with increased self-compassion, with neural changes predicting sustained nonjudging elevations two months later.

Abstract

Background: Ayahuasca is a plant tea containing the psychedelic 5-HT2A agonist N,N-dimethyltryptamine and harmala monoamine-oxidase inhibitors. Acute administration leads to neurophysiological modifications in brain regions of the default mode network, purportedly through a glutamatergic mechanism. Post-acutely, ayahuasca potentiates mindfulness capacities in volunteers and induces rapid and sustained antidepressant effects in treatment-resistant patients. However, the mechanisms underlying these fast and maintained effects are poorly understood. Here, we investigated in an open-label uncontrolled study in 16 healthy volunteers ayahuasca-induced post-acute neurometabolic and connectivity modifications and their association with mindfulness measures.

Methods: Using 1H-magnetic resonance spectroscopy and functional connectivity, we compared baseline and post-acute neurometabolites and seed-to-voxel connectivity in the posterior and anterior cingulate cortex after a single ayahuasca dose.

Results: Magnetic resonance spectroscopy showed post-acute reductions in glutamate+glutamine, creatine, and N-acetylaspartate+N-acetylaspartylglutamate in the posterior cingulate cortex. Connectivity was increased between the posterior cingulate cortex and the anterior cingulate cortex, and between the anterior cingulate cortex and limbic structures in the right medial temporal lobe. Glutamate+glutamine reductions correlated with increases in the "nonjudging" subscale of the Five Facets Mindfulness Questionnaire. Increased anterior cingulate cortex-medial temporal lobe connectivity correlated with increased scores on the self-compassion questionnaire. Post-acute neural changes predicted sustained elevations in nonjudging 2 months later.

Conclusions: These results support the involvement of glutamate neurotransmission in the effects of psychedelics in humans. They further suggest that neurometabolic changes in the posterior cingulate cortex, a key region within the default mode network, and increased connectivity between the anterior cingulate cortex and medial temporal lobe structures involved in emotion and memory potentially underlie the post-acute psychological effects of ayahuasca.

Comparable studies

Other non-randomized and open-label trials on ayahuasca, most cited first.

Study Year Design Participants
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Patients with recurrent depression 2015 Open-label trial n = 17
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial. Individuals with recurrent major depressive disorder 2021 Open-label trial (secondary analysis) n = 17
Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety Male patients in an inpatient addiction treatment program 2020 Pre-post observational study n = 31
Long-term effects of ayahuasca in patients with recurrent depression: a 5-year qualitative follow-up Patients with treatment-resistant major depressive disorder who had participated in an... 2018 Long-term follow-up of an open-label trial n = 8
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine. Healthy male subjects 2023 Open-label within-subject study n = 10

Citations in the library

Explore topics